Intraductal Papilloma with Benign Pathology on Breast Core Biopsy: To Excise or Not?
暂无分享,去创建一个
J. Palazzo | A. Berger | T. Tsangaris | Sanchi Malhotra | T. Tatarian | Claire M Sokas | Miguel L. Rufail | M. Lazar | Elizabeth Hsu | Talar Tatarian | Claire M. Sokas
[1] Jeffrey R Hawley,et al. Outcomes of benign breast papillomas diagnosed at image-guided vacuum-assisted core needle biopsy. , 2015, Clinical imaging.
[2] S. Raza,et al. Papilloma on Core Biopsy: Excision vs. Observation , 2015, Annals of Surgical Oncology.
[3] Carol Reynolds,et al. Management of Benign Intraductal Solitary Papilloma Diagnosed on Core Needle Biopsy , 2013, Annals of Surgical Oncology.
[4] Catherine M. Appleton,et al. Pathologic outcomes of nonmalignant papillary breast lesions diagnosed at imaging-guided core needle biopsy. , 2012, Radiology.
[5] W. Cheng,et al. Nonmalignant Breast Papillary Lesions at Core-Needle Biopsy: A Meta-analysis of Underestimation and Influencing Factors , 2012, Annals of Surgical Oncology.
[6] Joseph P. Costantino,et al. Update of the National Surgical Adjuvant Breast and Bowel Project Study of Tamoxifen and Raloxifene (STAR) P-2 Trial: Preventing Breast Cancer , 2010, Cancer Prevention Research.
[7] F. Tavassoli,et al. Papillary neoplasms of the breast: a review. , 2009, Archives of pathology & laboratory medicine.
[8] S. Jaffer,et al. Excision is indicated for intraductal papilloma of the breast diagnosed on core needle biopsy , 2009, Cancer.
[9] S. Raza,et al. Management of Intraductal Papillomas of the Breast: An Analysis of 129 Cases and Their Outcome , 2009, Annals of Surgical Oncology.
[10] Christopher Mills,et al. Papillary lesions of the breast diagnosed by core needle biopsy: 71 cases with surgical follow-up. , 2009, American journal of surgery.
[11] V. Vogel. The NSABP Study of Tamoxifen and Raloxifene (STAR) trial , 2009, Expert review of anticancer therapy.
[12] C. Mercado,et al. Breast Papillomas in the Era of Percutaneous Needle Biopsy , 2008 .
[13] W. Wood,et al. Surgical Follow-Up and Clinical Presentation of 142 Breast Papillary Lesions Diagnosed by Ultrasound-Guided Core-Needle Biopsy , 2008, Annals of Surgical Oncology.
[14] L. Jackson,et al. Multiple papillomas of the breast: is current management adequate? , 2006, Breast.
[15] L. Liberman,et al. Is surgical excision warranted after benign, concordant diagnosis of papilloma at percutaneous breast biopsy? , 2006, AJR. American journal of roentgenology.
[16] L. Ford,et al. Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study. , 2005, Journal of the National Cancer Institute.
[17] V Shane Pankratz,et al. Benign breast disease and the risk of breast cancer. , 2005, The New England journal of medicine.
[18] S. N. Agoff,et al. Papillary lesions of the breast with and without atypical ductal hyperplasia: can we accurately predict benign behavior from core needle biopsy? , 2004, American journal of clinical pathology.
[19] A. Renshaw,et al. Papillomas and atypical papillomas in breast core needle biopsy specimens: risk of carcinoma in subsequent excision. , 2004, American journal of clinical pathology.
[20] N. Sneige,et al. Accuracy of core needle biopsy diagnosis in assessing papillary breast lesions: histologic predictors of malignancy , 2004, Modern Pathology.
[21] Mary Scott Soo,et al. Imaging-guided core needle biopsy of papillary lesions of the breast. , 2002, AJR. American journal of roentgenology.
[22] S. Schnitt,et al. Nonmalignant Lesions in Breast Core Needle Biopsies: To Excise or Not to Excise? , 2002, The American journal of surgical pathology.
[23] G. Sakorafas. Nipple discharge: current diagnostic and therapeutic approaches. , 2001, Cancer treatment reviews.
[24] L. Liberman,et al. Percutaneous large-core biopsy of papillary breast lesions. , 1999, AJR. American journal of roentgenology.
[25] C K Redmond,et al. Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. , 1999, Journal of the National Cancer Institute.
[26] W. Dupont,et al. Subsequent breast carcinoma risk after biopsy with atypia in a breast papilloma , 1996, Cancer.
[27] L. Jardines. Management of nipple discharge. , 1996, The American surgeon.